FDA Clearance Tracker · P990017-S017
ANCURE ENDOGRAFT SYSTEM
Last checked: Nov 20, 2026Latest source record: Aug 17, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Aug 17, 2001
Approved
Time to decision
122 days
Received Apr 17, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P990017-S017
- Device name
- ANCURE ENDOGRAFT SYSTEM
- Applicant
- Boston Scientific Corp
- Applicant location
- St Paul, MN
- Received
- Apr 17, 2001
- Decided
- Aug 17, 2001
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P990017
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR LABELING CHANGES, INCLUDING USE OF STENTS AND GUIDEWIRES, AND JACKET RETRACTION TECHNIQUE.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.